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Objective: To date only a few randomized controlled studies have compared grafting strategies in patients with
multi-vessel coronary disease. This study represents a pilot RCT designed to test the feasibility of a trial comparing
conventional CABG performed with a LIMA-LAD plus saphenous vein grafts (LIMA+SVG) and CABG performed with
total arterial grafting (TAG).
Methods: Consenting patients undergoing non-redo isolated CABG surgery at a single institution were randomized
to TAG or LIMA+SVG groups. Exclusion criteria included prior CABG, emergent procedure, concomitant procedure,
varicose veins and renal dysfunction. The primary endpoints were: enrolment >20% and completion of CT coronary
angiography at 6 months >80%. Statistical investigation was performed on an intention to treat analysis.
Results: Of 421 eligible patients, 60 were enrolled and 2 withdrew (n = 30 in TAG, n = 28 LIMA+SVG) for 14%
enrolment rate. Patient characteristics were similar in each group. No patients died in hospital and adverse events
such as MI, stroke and deep sternal wound infection were not significantly different between groups. Clinical
follow-up was complete in 100% of patients, with 44/58 (76%) undergoing CT coronary angio at 6 months. Graft
occlusion occurred in 2 patients in each group for patency rates of 89% (TAG) and 91% (LIMA+SVG).
Conclusions: We provide evidence that an RCT comparing grafting strategy is possible but also show that
achieving recruitment or follow-up CT may be difficult. Given the excellent patency results and little difference
between groups, our findings suggest that the sample size required may make it infeasible to compare graft
patency at 6 months as a study end-point.
Trial registration: Randomized Controlled Trial number: ISRCTN80270323.
Ultra-mini abstract: Few RCT’s exist comparing conventional CABG performed with a LIMA-LAD plus saphenous
vein grafts (LIMA+SVG) compared to CABG performed with total arterial grafting (TAG). This study is a pilot RCT
designed to test the feasibility of such a trial and identify pitfalls.
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Grafting of the left internal mammary artery (LIMA) to left
anterior descending artery (LAD) is the established standard
of care during coronary artery bypass graft (CABG) surgery
[1]. However, grafting strategies to territories other than the
LAD, involving the use of either arterial grafts versus saphe-
nous vein(s) is still a matter of debate. This in spite of evi-
dence suggesting superior patency and better long-term
clinical outcome with arterial grafts [2-5]. This is reflected in
the overall use of total arterial grafts, which remains very
low, with less than 5% in patients within the Society of
Thoracic Surgery (STS) Adult Cardiac Surgery database re-
ceiving multiple arterial grafts [6].
Most of the evidence favoring multiple arterial grafts
has been obtained from retrospective analysis of large
registry data [2-5]. These studies suggest that the use of
multiple arterial grafts may improve long-term survival
after CABG. A limited number of randomized controlled
trials have been published examining all arterial grafting
strategies without consistent findings. In a randomized
controlled trial of 160 patients, Muneretto et al., demon-
strated superior graft patency and lower return of angina
in TAG patients [7]. In contrast, a randomized con-
trolled trial involving 331 patients, Damgaard et al., was
unable to show any significant differences in patency or
clinical endpoints between TAG vs. LIMA+SVG grafting
strategies at one year follow up [8]. Of note the primary
outcomes for the study from Damgaard et al. were graft
patency and cardiac event –free survival at 1 year.
The above reported randomized study highlight conflict-
ing evidence in the literature and the relative paucity of de-
finitive large randomized studies comparing total arterial
grafting strategy (TAG) to saphenous vein and arterial
grafting strategy. We sought in the present trial to test the
feasibility of conducting such a trial by performing first a
small-scale pilot trial in which barriers would be explored
including taking into consideration individual surgeon prac-
tice as part of our analysis. In the present study we will dem-
onstrate 3 important barriers to consider in designing a
definitive trial comparing grafting strategy with TAG versus
LIMA+SVG and how these can impact feasibility.
Methods
Randomized control trial study design
Given the paucity of randomized evidence available to
guide surgeons in choosing the best grafting strategy for
their patients, the present study was designed as a pilot
prospective randomized controlled trial comparing total
arterial grafting (TAG) to conventional grafting using a
LIMA to the LAD and saphenous vein grafts for the
other territories (LIMA+SVG) in patients undergoing
non-redo isolated CABG.
Patients were excluded from enrolment if they were
scheduled to undergo emergent surgery, single vesselbypass surgery, had received a prior CABG or displayed
evidence of varicose veins on pre-operative physical exam-
ination. In addition, patients with a documented history of
chest radiotherapy, allergy to contrast media and renal in-
sufficiency (defined by serum creatinine > 176 μmol/L),
were also excluded.
Informed consent was obtained from all patients in ac-
cordance with our institutional research ethics review
board guidelines (Randomized Controlled Trial number:
ISRCTN80270323). Once the patient had consented, he
or she was randomized prior to entering the operating
room. The randomization process was performed using
random permuted blocks with varying block sizes of 4, 6
and 8. Numbered index cards were placed in sealed,
opaque envelopes and stored safely with the research co-
ordinator. Consented patients were randomized prior to
surgery, and the surgeon opened the envelope in the op-
erating room before starting the case. The index card in-
dicated whether the patient was to be randomized to
TAG or LIMA+SVG. If the surgeon decided intra-
operatively that the patient could not undergo the pro-
cedure to which he or she was randomized, the patient
was offered the revascularization strategy most likely to
afford the patient the best possible outcome. If the pa-
tient required a concomitant cardiac procedure (e.g.
valve replacement or repair) or could not undergo a re-
vascularization procedure with a minimum of two distal
bypasses, the patient was excluded from the study.
Primary outcome
The primary objectives of our pilot study were to evaluate
the feasibility of a larger randomized trial in current car-
diac surgical practice in which individual surgeon prefer-
ences have been suggested to play a large role in choosing
grafting strategies [1]. Feasibility was defined as our ability
to recruit more than 20% of eligible patients and assess
completion of CT-coronary angiography in greater than
80% of patients at 6 month follow-up.
Secondary outcome
The secondary objectives of the study were to compare
postoperative graft patency and in-hospital mortality and
morbidity. In addition the quality of graft imaging was also
examined. All analysis was performed on an intent-to-treat
basis. The treating team and patients were not blinded to
the treatment allocation. However, CT-coronary angiograms
were reviewed in a blinded manner by a single radiologist.
Operative technique
All interventions were performed via a midline sternotomy,
and cardiopulmonary bypass was utilized in a standardized
manner for all cases. Body temperature during the proced-
ure was allowed to drift briefly to 32°C. Intermittent cold
blood cardioplegia solution was delivered anterograde via
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duits were harvested with minimal trauma (LIMA and
RIMA were not skeletonized) and were treated with either
a papaverine solution or a nitroglycerine/calcium channel
blocker (verapamil) solution prior to their use. TAG was
defined as the use of any arterial conduit (LIMA, RIMA
or radial artery), either alone or in combination, without
concomitant use of SVG. The choice of conduit and the
manner in which the grafts were constructed, including
composite T- or Y-grafts, proximal aorto-coronary anasto-
moses or sequential anastomoses, was based entirely on
surgeon preference rather than on any fixed criteria such
as territory to graft or degree of target vessel stenosis.
LIMA+SVG was defined as any case in which the LIMA
was used for a single bypass to the LAD and SVGs were
used for the remaining bypasses, constructed as either a
series of sequential anastomoses or as single bypasses and
were anastomosed proximally to the aorta.
Post- operative management
All study patients received postoperative intravenous nitro-
glycerine infusions for the first 24 hours upon return from
the operating room unless hypotensive (systolic blood
pressure < 90 mm Hg). Other routine post-operative
medications included daily aspirin as well as resumption of
cholesterol lowering agents, B-blockers and angiotensin con-
verting enzyme inhibitors as appropriate.
CT-coronary angiography
All study patients received CT angiography 6 months post
CABG. This was performed on a 64 slice multi-detector
CT scanner (Siemens Sensation 64, Erlangen, Germany),
using the following scan parameters: 330 ms gantry rota-
tion, detector collimation 32 × 0.6 mm (with a rapidly alter-
nating focal spot resulting the acquisition of 64 slices per
gantry rotation with effective special resolution of 0.4 mm),
tube voltage 120 kV, maximum obtainable tube current
(800 – 900 mAs) scanning in a caudo-cranial direction. Ret-
rospecive ECG gating was used with ECG pulsing such that
full tube current was applied between 50% and 80% of the
cardiac cycle, and reduced to 40% during the remainder.
One hundred mL of contrast agent (Isovue 370, Bracco,
Italy) was injected into a right antecubital vein via an 18-
guage cannula at a flow rate of 5 mL/s, followed by 40 mL
of normal saline bolus chaser at a rate of 5 mL/s. All pa-
tients with heart rate >65 beats per minute, unless contra-
indicated, received beta blocker in the form of 50 mg oral
metoprolol, 0.2 micrograms of sublingual glycerol trinitrate,
plus or minus 1–2 mg oral lorazepam prior to being
scanned in order to reduce heart rate and maximize the
lumen diameter of the coronary artery bypass grafts. Axial
data sets with a slice thickness 0.75 mm and slice interval
0.6 mm, were reconstructed using a medium smooth re-
construction kernel (B30f) at the following intervals duringthe cardiac cycle (20%, 55%, 60%, 65%, 70%, 75%). Further
datasets from different time intervals or at a sharper
reconstruction kernel (B46f) were reconstructed at the
interpreting radiologist’s discretion. Interpretation of all CT
angiograms was performed by a single level 3 trained cardiac
radiologist who was blinded to the treatment allocation.
Each bypass graft was assessed for image quality with
graft visualization determined as excellent, diagnostic or
non-diagnostic. The presence or absence of artifact was
noted with the following categories: none, clip, rhythm,
respiratory motion and other. Heart rate and heart
rhythm during the CTA acquisition were recorded.
Each bypass graft for which visualization was determined
not to be non-diagnostic was visually assessed using axial
data, multi-planar reformats and curved planar reformats as
per Society of Cardiovascular Computed Tomography
guidelines and assigned to one of three categories: Occluded
(defined as any focus where there was complete lack of
luminal contrast), luminal stenosis of greater than 50%, or
patent (no luminal stenosis greater than 50%) [9].
Data sources
The Maritime Heart Center (MHC) Cardiac Surgery
Registry captures pre-operative, intra-operative and in-
hospital post-operative clinical variables including mortal-
ity and morbidity for all patients undergoing cardiac
surgery at the QEII Health Sciences Centre in Nova
Scotia, Canada. Pre-operative variables included age, sex,
body mass index (BMI), smoking history, diabetes, hyper-
cholesterolemia, hypertension, peripheral and/or cerebro-
vascular disease, chronic obstructive pulmonary disease,
left ventricular ejection fraction (EF), myocardial infarc-
tion within 21 days prior to surgery, urgency of surgery
(urgent patients required surgery within 24 hours, in-
house patients were waiting in-hospital, elective patients
were waiting at home), prior percutaneous coronary inter-
vention, left main stenosis >50%, and number of diseased
vessels. In-hospital outcomes included all-cause mortality,
stroke (neurological deficit persisting at time of hospital
discharge), peak troponin T, deep sternal wound infection,
mechanical ventilation >24 hours, and postoperative
length of stay in hospital >9 days. Aortic cross-clamp time
was also reported.
Statistical analysis
The TAG and LIMA+SVG groups were compared using
Chi-square or Fisher’s exact tests for categorical variables,
two-tailed t-tests for continuous variables that were nor-
mally distributed, and Wilcoxon rank sum tests for con-
tinuous variables that did not have a normal distribution.
One of the primary objectives was > 20% recruitment of
patients into the randomized trial. Patient eligibility was
based on inclusion and exclusion criteria and assignment
to participating surgeons. This allowed for the creation of







Age≥ 70 4 (13) 5 (18) 0.73
Female 1 (3) 1 (4) 0.99
BMI < 25 kg/m2 3 (10) 4 (14) 0.70
Smoking history 24 (80) 20 (71) 0.45
Diabetes mellitus 9 (30) 6 (21) 0.46
Hypercholesterolemia 25 (83) 27 (96) 0.20
Hypertension 22 (73) 23 (82) 0.42
Myocardial infarction≤ 21 days 2 (7) 4 (14) 0.42
EF < 40% 1 (3) 0 (0) 0.99
PVD and/or CVD 3 (10) 2 (7) 0.99
COPD 2 (7) 3 (11) 0.67
Left main stenosis > 50% 9 (30) 7 (25) 0.67
Triple vessel disease 20 (67) 16 (57) 0.46
Prior PCI 3 (10) 3 (11) 0.99
Urgency of surgery: 0.39
Elective 22 (73) 18 (64)
In-house 7 (23) 10 (36)
Urgent < 24 hours 1 (3) 0 (0)
Categorical variables are shown as number (percent).
TAG: total arterial grafting; LIMA: left internal mammary artery; SVG: saphenous
vein graft; BMI: body mass index; EF: left ventricular ejection fraction; CVD:
cerebrovascular disease; PVD: peripheral vascular disease; COPD: chronic
obstructive pulmonary disease; PCI: percutaneous coronary intervention.
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dicted use of TAG. Design variables were created for refer-
ence level coding of categorical variables with more than
two levels. For the multivariable analysis, candidate vari-
ables were selected based on clinical relevance or a signifi-
cance of bivariate association with p value <0.2. A non-
parsimonious logistic regression model was developed to
identify the predictors of receiving TAG. The area under
the receiver operating characteristic (ROC) curve was
used to assess predictive accuracy of the model. A boot-
strap procedure was used to obtain 1000 subsamples with
replacement. The 2.5th and 97.5th percentiles of the boot-
strap distribution were then used to determine the 95%
Confidence Interval (CI) of the ROC.
All statistical analyses were performed using the SAS
software package version 9.2 (SAS, Cary, North Carolina).
Results
Study population
During the study period, 421 patients met the eligibility
criteria for participation in the trial. From this group of
eligible patients, a total of 60 consented patients were
randomized into 2 groups: TAG or LIMA+SVG. Two
patients withdrew from the study leaving 58 patients
(TAG: n = 30, LIMA+SVG: n = 28). The two study
groups did not differ significantly in age, sex, EF, triple
vessel disease, or other preoperative clinical characteris-
tics (Table 1).
Unadjusted in-hospital outcomes are shown in Table 2.
There was no in-hospital mortality in either TAG or
LIMA+SVG group. Furthermore no statistically signifi-
cant differences were detected in stroke, deep sternal
wound infection, mechanical ventilation >24 hours or
postoperative length of stay >9 days. Peak troponin T
and aortic cross-clamp time were significantly higher in
the TAG group.
Primary endpoints of the trial
The primary objectives were to recruit > 20% of eligible
patients and to complete 6-month follow-up CT-coronary
angiography in > 80% of study patients. The primary ob-
jectives of this study were not achieved with only 14.3% of
eligible patients recruited (60/421) and 76% (44/58) of pa-
tients completing CT angiography. Of the 58 patients in
the study clinical follow-up was complete in 100% of pa-
tients (Figure 1).
Graft patency assessed by CT angiography
A total of 44 patients underwent CT angiography (23:
TAG and 21: LIMA+SVG). Graft occlusion was observed
in 2 patients (9%) in the TAG group and 2 patients (10%)
in the LIMA+SVG groups (p = 0.99). Significant graft ab-
normality defined as graft occlusion or stenosis > 50% was
present in 3 patients (13%) in TAG group and 3 patients(14%) in LIMA+SVG groups p = 0.99). We then compared
the patency at 6 months between arterial grafts and saphe-
nous vein grafts outside of their group allocation. There
were a total of 83 arterial grafts compared to 34 saphe-
nous grafts. In this analysis (n = 117 grafts), CT angiog-
raphy demonstrated that graft patency was greater than
95% in both groups (p = 0.99).
The quality of images was also analyzed as an endpoint in
this pilot trial. It should be noted that visualization of 7 out
of 117 grafts (6%) was determined to be non-diagnostic.
This was observed in 5 patients in TAG group compared to
1 patient in LIMA+SVG group (p = ns). Four of the six non-
diagnostic grafts were sequential grafts to the lateral wall of
the left ventricle when compared to free radial graft to the
inferior or lateral wall. The most common reason for diffi-
culty visualizing was clip artifact. Details on patients and
grafts that were non-diagnostic are illustrated in Table 3.
Predictors of total arterial grafting
We created a non-parsimonious logistic regression model
predicting the probability of a CABG patient receiving TAG
during the entire study period in order to better understand
variables responsible for patient selection. The following
variables were included in the model: surgical volume
Table 2 Unadjusted postoperative in-hospital outcomes
TAG n = 30 LIMA+SVG n = 28 P value
All cause mortality 0 (0) 0 (0) -
Stroke 2 (7) 0 (0) 0.49
Deep sternal wound infection 0 (0) 0 (0) -
Mechanical ventilation > 24 hours 3 (10) 0 (0) 0.24
Postoperative length of stay > 9 days 4 (13) 1 (4) 0.35
Peak troponin T, ng/mL 0.38 (0.21 – 0.55) 0.22 (0.13 – 0.30) 0.0051
Aortic cross-clamp time, minutes 86 (61 – 110) 56 (44 – 66) 0.0046
Categorical variables are shown as number (percent), and continuous variables are shown as median (inter-quartile range).
TAG: total arterial grafting; LIMA: left internal mammary artery; SVG: saphenous vein graft.
Assessed for eligibility (n= 421) 
Did not participate (n= 362) 
-Decline to participate  
-Failed to be approached  
-Undisclosed surgeon preference
Randomized (n =60) 
Allocated to TAG group (n=30) 
Received allocated intervention (30) 
Allocated to LIMA+SVG group (n=30) 
Received allocated intervention 
(n=28) 
 Did not receive allocated 
intervention (No longer wanted to 
participate ( n=2))
Lost to follow up (n=0) Lost to follow up (n=0) 
Analyzed (n=30) 
Excluded from analysis (n=0)  
Analyzed (n =28) 
Excluded from analysis (n=2) 
Figure 1 Flow diagram primary outcome.
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Table 3 Features of patients in which grafts visualization was difficult
Group Reason for poor visualization HR and Rhythm Type of graft
#1 TAG Clip artifact NSR, HR < 65 Sequential RIMA to OM and PDA
#2 TAG Clip and rhythm artifact NSR, HR < 63 Sequential RIMA to OM1 and OM2
#3 TAG Clip and respiratory artifact NSR, HR < 74 Free radial to OM1
#4 TAG Clip and rhythm artifact NSR, HR < 84 Free radial to PDA
#5 TAG Clip artifact NSR, HR < 69 Sequential graft to OM and LVb
#6 LIMA+SVG Clip artifact NSR, HR < 68 Sequential graft SVG to LVb and PDA
HR: heart rate; TAG: total arterial grafting; NSR: normal sinus rhythm; RIMA: right internal mammary artery; OM: obtuse marginal branch of the circumflex;
PDA: posterior descending artery; LVb: left ventricular branch of the circumflex; SVG: saphenous vein graft.
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sex, BMI, EF and urgency of surgery. A plot of the variables
with adjusted odds ratios is shown in Figure 2. The model
had good predictive accuracy with an ROC of 86% and 95%
confidence interval 83% - 90%. The strongest predictor was
surgeon volume in performing TAG, independent of other
clinically relevant variables such as age, sex, EF, BMI and
urgency of surgery. Our findings would suggest that only
surgeons who perform TAG more than 15% of the time are
most likely to perform TAG and as such likely to enroll pa-
tients in this type of trial.
Discussion
Numerous studies based on registry data have suggested
that multiple arterial grafting in CABG patients provides
a survival benefit over conventional CABG performedFigure 2 Plot of adjusted odds ratios and 95% confidence intervals fo
left ventricular ejection fraction; BMI: body mass index.with a LIMA graft to the LAD and saphenous veins
[2-5]. However, there have been few randomized studies
have addressed this question [7,8]. In fact, this paucity of
high-level evidence supporting the use of multiple arter-
ial grafts may be responsible at least in part to the lim-
ited adoption of multiple arterial grafts. This lack of
adoption is best illustrated by the fact that less than 5%
of CABG patients in the STS database receive multiple
arterial grafts [6].
The objective of the present pilot study was to look at
the feasibility of conducting such a randomized study
comparing grafting strategies. We defined feasibility as the
ability to recruit a reasonable proportion of patients and
to ensure that the majority would complete the follow-up.
The recruitment was set at 20% of eligible patients, which
represents a conservative estimate so that findings fromr predictors of total arterial grafting. TAG: total arterial grafting; EF:
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practice rather than highly selected cases. Study follow-up
was defined as completion of a CT-angiogram at 6 month
after surgery in more than 80% of patients. In this pilot
study we failed to meet the primary objective with a re-
cruitment of 14.3% of eligible patients and completion of
CT angiography in 76% of patients. Our findings suggest
therefore that a primary trial comparing TAG versus con-
ventional CABG may be plagued by poor recruitment,
which could compromise the generalizability of the
findings.
However, the present study did demonstrate that in se-
lected patients, CABG surgery can be safely performed
with both grafting strategies ie. TAG or LIMA+SVG. In
the 58 patients in the study there was no in-hospital mor-
tality. However, it should be noted that TAG patients re-
quired longer clamp times and had significant higher
Troponin T levels post-operatively. This findings is of im-
portance given evidence that increased incidence of myo-
cardial injury has been shown to impact outcomes after
surgery [10,11]. While we reported in our study no new q
wave myocardial infarction, our findings suggest that TAG
patients may be at higher risk for myocardial injury
assessed by a sensitive Troponin assay. We speculate that
the Troponin rise is likely multifactorial but could easily
be related to the longer cross-clamp times. Our observed
longer cross clamp time highlights inherent higher tech-
nical challenges in using only arterial grafts compared to
their venous counterparts which in our study translated in
longer myocardial exposure to ischemia. The methods
used for myocardial protection were identical between
groups suggesting that our observation is unlikely related
to inadequate myocardial protection.
In the patients that had follow-up CT angiography
(76% of patients), graft patency in both groups of pa-
tients was found to be greater than 90%. Our findings of
similar 6-month patency between groups would suggest
that a very large study would be required to be able to
detect a patency difference between groups. The ob-
served excellent early graft patency in combination with
the limited outcome differences between grafting strat-
egies makes the design of any future large RCT difficult.
In the present pilot the lack of differences observed
would suggest that an appropriately powered definitive
study based on patency as an outcome would need to be
prohibitively large. Our findings contrast with lower pa-
tency rates in saphenous vein grafts from older contem-
porary studies [12]. However, our findings of greater
than 90% patency are remarkably similar to findings
from recent trials in which graft patency was used as a
primary outcome supporting our findings [13]. Taken to-
gether it is increasingly apparent that any benefit of
TAG over conventional grafting may not manifest until
much later in time making the design of a definitivestudy problematic. This is best illustrated by findings
from large registries were the benefits increase with time
but only become apparent after 10 years [2]. This is also
apparent from findings from the ART trial comparing
single IMA to bilateral IMA in which results at one year
are comparable [14].
In the present study we chose to evaluate graft patency
between groups with CT- Angiography based on its limited
invasiveness, safety and reported accuracy in assessing graft
patency [9]. However, we were surprised to report that sig-
nificant difficulty in assessing graft patency may be an issue
in up to 5% of grafts, particularly when evaluating sequential
grafts on the lateral wall. Previous authors using the same
scanner hardware and similar scanning protocols have re-
ported varying results in terms of non – evaluable grafts
ranging from 0% to 13% [15-18]. More recent studies using
improved hardware and scanning protocols have also re-
ported a small percentage of non-evaluable grafts [19]. In
support of our observation is the observation by others that
arterial grafts to the lateral wall may be particularly difficult
to visualize [20]. Although the absolute numbers of non-
diagnostic grafts are small, the low incidence rate of stenosis
or occlusion calls into question the utility of CT-angio for
the purpose of graft evaluation in this study population. Our
findings appear to confirm that coronary angiography re-
mains the gold standard for evaluation of coronary artery
bypass grafts patency. More importantly for the design of
endpoints in a trial comparing grafting strategies our ob-
served difficulty with graft visualization would need to be
taken into consideration for power calculations. One should
note that CT technology is continuing to improve signifi-
cantly such that this limitation may no longer be an issue in
the future.
During the study period 421 patients were eligible for en-
rolment in the trial based on inclusion and exclusion cri-
teria. However, only 60 patients (14.3%) were randomized
and 2 of these patients withdrew. Recruitment was largely
left to the participating surgeons making surgeon preference
a major determinant of revascularization strategy. This ex-
plains why in this part of the manuscript we decided to ex-
plore clinical reasons why patients may not have been
enrolled by creating a predictive model to determine the
relative role of clinical variables in the decision making of
surgeons to perform TAG outside of the trial. This approach
was used to estimate the relative roles of surgeon preference
as compared to objective clinical reasons for determining
the use of TAG grafting. As one would expect patients who
were older, required more urgent procedures and had more
co-morbidities were least likely to undergo TAG. However,
what is novel about our analysis is that surgeon was one of
the most robust predictors of grafting strategy independent
of all clinical variables. We interpret this finding as being
highly suggestive that surgeons select patients for particular
grafting strategy based on variables that are not captured by
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speculate that surgeon also use inherent biases about the
relative benefit of one grafting strategy over another. Despite
the above findings, we acknowledge that we remain unable
to determine why exactly a particular patient was not
enrolled.
Conclusion
In summary, we have been able to demonstrate 3 important
reasons why a trial comparing grafting strategy with TAG
versus LIMA+SVG may be challenging. These reasons in-
clude a significant risk for slow enrolment, very small out-
come differences between groups making clinically relevant
conclusions difficult and limitations of using CT-angio as a
tool to measure graft patency for the primary outcome. We
therefore conclude that a larger multicenter study compar-
ing graft patency of TAG vs. LIMA+SVG may not be feas-
ible with the current design of the study in which early
patency result would be the primary outcome. Our findings
have important implications for the design of any future
study in which grafting strategies are to be considered. The
implications relate to the apparent limited differences in out-
come differences early, limited patency differences early,
methods by which grafts are assessed and inherent bias of
surgeons making recruitment difficult. This means that
longer-term clinical endpoints are likely most appropriate
for the design of any future RCT to compare grafting strat-
egies in cardiac surgery.
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